{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:16:15Z","timestamp":1789989375904,"version":"4.0.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T00:00:00Z","timestamp":1546905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Gilead Sciences Europe","award":["This work was funded by Gilead Sciences Europe. Gilead had no influence on the development, research or writing of the manuscript"],"award-info":[{"award-number":["This work was funded by Gilead Sciences Europe. Gilead had no influence on the development, research or writing of the manuscript"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12889-018-6357-x","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T15:49:41Z","timestamp":1546962581000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe"],"prefix":"10.1186","volume":"19","author":[{"given":"H.","family":"St\u00f6ver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Meroueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Keppler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Saiz de la Hoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Littlewood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Nava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Walcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Somaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,8]]},"reference":[{"issue":"Suppl 2","key":"6357_CR1","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1093\/cid\/cit302","volume":"57","author":"G Robaeys","year":"2013","unstructured":"Robaeys G, Grebely J, Mauss S, Bruggmann P, Moussalli J, De Gottardi A, et al. Recommendations for the management of hepatitis C virus infection among people who inject drugs. Clin Infect Dis. 2013;57(Suppl 2):S129\u201337 [cited 7 Dec 2015].","journal-title":"Clin Infect Dis"},{"key":"6357_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/MEG.0000000000000855","volume":"29","author":"C Roncero","year":"2017","unstructured":"Roncero C, Vega P, Martinez-Raga J, Torrens M. Chronic hepatitis C and individuals with a history of injecting drugs in Spain: population assessment, challenges for successful treatment. Eur J Gastroenterol Hepatol. 2017;29:629\u201333.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"6357_CR3","doi-asserted-by":"publisher","unstructured":"Bielen R, Stumo SR, Halford R, Werling K, Reic T, St\u00f6ver H, et al. Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries. Harm Reduct J. 2018;15. \n                    https:\/\/doi.org\/10.1186\/s12954-018-0230-1\n                    \n                  .","DOI":"10.1186\/s12954-018-0230-1"},{"key":"6357_CR4","doi-asserted-by":"crossref","unstructured":"Wright N, Reimer J, Somaini L, Roncero C, Maremmani I, Simon N, et al. Are we ready to treat hepatitis C virus in individuals with opioid use disorder: assessment of readiness in European countries on the basis of an expert-generated model. Eur J Gastroenterol Hepatol. 2017;29:1206\u201314.","DOI":"10.1097\/MEG.0000000000000962"},{"key":"6357_CR5","unstructured":"Li V, Chen J. The burden of hepatitis C in the injection drug user population the framework of stigma. J Glob Health. 2014. Available from: \n                    http:\/\/www.ghjournal.org\/the-burden-of-hepatitis-c-in-the-injection-drug-user-population\/\n                    \n                  . [cited 30 Aug 2017]."},{"key":"6357_CR6","doi-asserted-by":"publisher","unstructured":"Daley DC. Family and social aspects of substance use disorders and treatment. J Food Drug Anal. 2013;21. \n                    https:\/\/doi.org\/10.1016\/j.jfda.2013.09.038\n                    \n                  .","DOI":"10.1016\/j.jfda.2013.09.038"},{"key":"6357_CR7","volume-title":"Problem drug users\u2019 experiences of employment and the benefit system","author":"L Bauld","year":"2010","unstructured":"Bauld L, Hay G, McKell J, Carroll C. Problem drug users\u2019 experiences of employment and the benefit system. 2010. ISBN 978 1 84712 729 7."},{"key":"6357_CR8","unstructured":"National Institute on Drug Abuse. Heroin - What are the medical complications of chronic heroin use? Heroin Res Rep Ser. 2014. Available from: \n                    https:\/\/www.drugabuse.gov\/publications\/research-reports\/heroin\/what-are-medical-complications-chronic-heroin-use\n                    \n                  . [cited 11 Jan 2018]."},{"key":"6357_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1747-597X-8-35","volume":"8","author":"K Lang","year":"2013","unstructured":"Lang K, Neil J, Wright J, Dell CA, Berenbaum S, El-Aneed A. Qualitative investigation of barriers to accessing care by people who inject drugs in Saskatoon, Canada: perspectives of service providers. Subst Abuse Treat Prev Policy. 2013;8:35.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"6357_CR10","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/dar.12357","volume":"35","author":"S Larney","year":"2016","unstructured":"Larney S, Cama E, Nelson E, Larance B, Degenhardt L. A cross-sectional study of correlates of imprisonment in opioid-dependent men and women in New South Wales, Australia. Drug Alcohol Rev. 2016;35:686\u201392.","journal-title":"Drug Alcohol Rev"},{"key":"6357_CR11","doi-asserted-by":"publisher","unstructured":"Bremer V, Cai W, Gassowski M, Hau\u00dfig J, Marcus U, Nielsen Stine. Abschlussbericht der Studie \u201cDrogen und chronische Infektionskrankheiten in Deutschland\u201d (DRUCK-Studie). Berlin: Robert Koch-Institut; 2016. Available from: \n                    https:\/\/doi.org\/10.17886\/rkipubl-2016-007\n                    \n                  . [cited 31 December 2018].","DOI":"10.17886\/rkipubl-2016-007"},{"key":"6357_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/epirev\/mxy002","volume":"40","author":"B Moazen","year":"2018","unstructured":"Moazen B, Moghaddam SS, Silbernagl MA, Lot M, Bosworth RJ, Alammehrjerdi Z, et al. Prevalence of drug injection, sexual activity, tattooing, and piercing among prison inmates. Epidemiol Rev. 2018;40:1\u201312.","journal-title":"Epidemiol Rev"},{"key":"6357_CR13","doi-asserted-by":"publisher","unstructured":"Lazarus JV, Safreed-Harmon K, Hetherington KL, Bromberg DJ, Ocampo D, Graf N, et al. Health outcomes for clients of needle and syringe programs in prisons. Epidemiol Rev. 2018;40. \n                    https:\/\/doi.org\/10.1093\/epirev\/mxx019\n                    \n                  .","DOI":"10.1093\/epirev\/mxx019"},{"key":"6357_CR14","unstructured":"Bielen R, Stumo S, Halford R, Werling K, Reic T, St\u00f6ver H, et al. Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries. Harm Reduct. J. 2018;15:25."},{"key":"6357_CR15","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0140-6736(16)30466-4","volume":"388","author":"K Dolan","year":"2016","unstructured":"Dolan K, Wirtz AL, Moazen B, Ndeffo-mbah M, Galvani A, Kinner SA, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet. 2016;388:1089\u2013102.","journal-title":"Lancet"},{"key":"6357_CR16","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.4254\/wjh.v7.i21.2323","volume":"7","author":"R Zampino","year":"2015","unstructured":"Zampino R, Coppola N, Sagnelli C, Di CG, Sagnelli E. Hepatitis C virus infection and prisoners: epidemiology, outcome and treatment. World J Hepatol. 2015;7:2323\u201330.","journal-title":"World J Hepatol"},{"key":"6357_CR17","first-page":"3","volume-title":"European public assessment reports. Hepatitis C, Chronic","author":"European Medicines Agency","year":"2018","unstructured":"European Medicines Agency. European public assessment reports. Hepatitis C, Chronic; 2018. p. 3\u20135."},{"key":"6357_CR18","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/add.13783","volume":"112","author":"J Stone","year":"2017","unstructured":"Stone J, Martin NK, Hickman M, Hutchinson SJ, Aspinall E, Taylor A, et al. Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland. Addiction. 2017;112:1302\u201314.","journal-title":"Addiction"},{"key":"6357_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1108\/IJPH-08-2015-0025","volume":"12","author":"MM Mina","year":"2016","unstructured":"Mina MM, Herawati L, Butler T, Lloyd A. Hepatitis C in Australian prisons: a national needs assessment. Int J Prison Health. 2016;12:3\u201316.","journal-title":"Int J Prison Health"},{"key":"6357_CR20","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/jvh.12580","volume":"23","author":"EJ Apsinall","year":"2016","unstructured":"Apsinall EJ, Mitchell W, Schofiled J, Cairns A, Lamond S, Bramley P, et al. A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy. J Viral Hepat. 2016;23:1009\u201316.","journal-title":"J Viral Hepat"},{"key":"6357_CR21","unstructured":"M\u00e9dicos y Pacientes. La SESP vincula el fin de la hepatitis C a su detecci\u00f3n en las c\u00e1rceles. Madrid; 2018. Available from: \n                    http:\/\/www.medicosypacientes.com\/articulo\/la-sesp-vincula-el-fin-de-la-hepatitis-c-su-deteccion-en-las-carceles\n                    \n                  . [cited 31 December 2018]."},{"key":"6357_CR22","volume-title":"Datos no publicados. N\u00famero de pacientes tratados en las prisiones dependientes de la administraci\u00f3n catalana (31 Diciembre 2017)","author":"Grupo Malalties Infecciosas Penitenciaries de ICS","year":"2017","unstructured":"Grupo Malalties Infecciosas Penitenciaries de ICS. Datos no publicados. N\u00famero de pacientes tratados en las prisiones dependientes de la administraci\u00f3n catalana (31 Diciembre 2017). 2017."},{"key":"6357_CR23","volume-title":"Antiviral Report for the Hepatitis C in the Community Valencia (01\/01\/2017 to 08\/31\/2017)","author":"Conselleria de Sanitat Universal i Salut P\u00fablica","year":"2017","unstructured":"Conselleria de Sanitat Universal i Salut P\u00fablica. Antiviral Report for the Hepatitis C in the Community Valencia (01\/01\/2017 to 08\/31\/2017). 2017. Available from: \n                    http:\/\/www.san.gva.es\/web_estatica\/index_es.html\n                    \n                  . [cited 4 May 2018]."},{"key":"6357_CR24","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","volume":"65","author":"D Hoy","year":"2012","unstructured":"Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65:934\u20139.","journal-title":"J Clin Epidemiol"},{"key":"6357_CR25","volume-title":"Spain. Country Drug Report - Drug use and responses in prison","author":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)","year":"2017","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Spain. Country Drug Report - Drug use and responses in prison. 2017. Available from: \n                    http:\/\/www.emcdda.europa.eu\/countries\/drug-reports\/2017\/spain\/drug-use-response-in-prison_en\n                    \n                  . [cited 27 Apr 2018]."},{"key":"6357_CR26","volume-title":"Art. 208. Sec. 1. Decreto 190\/1996, de 9 de febrero, por el que se aprueba el Reglamento Penitenciario. TITULO IX. De las prestaciones de la Administraci\u00f3n Penitenciaria","author":"Ministerio de Justica e Interior","year":"1996","unstructured":"Ministerio de Justica e Interior. Art. 208. Sec. 1. Decreto 190\/1996, de 9 de febrero, por el que se aprueba el Reglamento Penitenciario. TITULO IX. De las prestaciones de la Administraci\u00f3n Penitenciaria. 1996. Available from: \n                    http:\/\/noticias.juridicas.com\/base_datos\/Penal\/rd190-1996.t9.html\n                    \n                  . [cited 9 Jan 2018]."},{"key":"6357_CR27","volume-title":"Prison Service Order ORDER NUMBER 3200 Health Promotion","author":"HM Prison Service","year":"2003","unstructured":"HM Prison Service. Prison Service Order ORDER NUMBER 3200 Health Promotion. 2003."},{"key":"6357_CR28","unstructured":"Loi n\u00b0 94\u201343 du 18 janvier 1994 relative \u00e0 la sant\u00e9 publique et \u00e0 la protection sociale. 1994. Available from: \n                    https:\/\/www.legifrance.gouv.fr\/affichTexte.do?cidTexte=JORFTEXT000000728979\n                    \n                  . [cited 1 May 2018]."},{"key":"6357_CR29","volume-title":"Ritorno della medicina penitenziaria a norma dell\u2019articolo 5 della legge, 30 November 1998 n. 419","author":"Ministero della Sanit\u00e0","year":"1999","unstructured":"Ministero della Sanit\u00e0. Ritorno della medicina penitenziaria a norma dell\u2019articolo 5 della legge, 30 November 1998 n. 419. 1999."},{"key":"6357_CR30","volume-title":"Allgemeine Regeln Strafvollzugsgesetz \u00a7 56","author":"Bundesrecht","year":"2009","unstructured":"Bundesrecht. Allgemeine Regeln Strafvollzugsgesetz \u00a7 56 2009. \n                    http:\/\/www.buzer.de\/gesetz\/1310\/a18531.htm\n                    \n                  ."},{"key":"6357_CR31","unstructured":"Ministerio de Sanidad SS e I. Plan estrat\u00e9gico para el abordaje de la hepatitis c en el sistema nacional de salud. Madrid. 2015. Available from: \n                    http:\/\/www.msssi.gob.es\/ciudadanos\/enfLesiones\/enfTransmisibles\/docs\/plan_estrategico_hepatitis_C.pdf\n                    \n                  . [cited 31 December 2018]."},{"key":"6357_CR32","volume-title":"Hepatitis C in England 2017 report\u00a0:Working to eliminate hepatitis C as a major public health threat","author":"Public Health England","year":"2017","unstructured":"Public Health England. Hepatitis C in England 2017 report\u00a0:Working to eliminate hepatitis C as a major public health threat. 2017."},{"key":"6357_CR33","volume-title":"Prise en charge th\u00e9rapeutique et suivi de l\u2019ensemble des personnes infect\u00e9es par le virus de l\u2019h\u00e9patite C","author":"D Dhumeaux","year":"2016","unstructured":"Dhumeaux D. Prise en charge th\u00e9rapeutique et suivi de l\u2019ensemble des personnes infect\u00e9es par le virus de l\u2019h\u00e9patite C; 2016."},{"key":"6357_CR34","unstructured":"NHS Commissioning DCCPT. Strategic direction for health services in the justice system: 2016-2020 Care not custody, care in custody, care after custody. p. 2016."},{"key":"6357_CR35","volume-title":"Hepatitis C prevention, diagnosis and treatment in prisons in England","author":"J Cox","year":"2016","unstructured":"Cox J, Dhuny J, Dodd J. Hepatitis C prevention, diagnosis and treatment in prisons in England; 2016."},{"key":"6357_CR36","volume-title":"Strat\u00e9gie Sant\u00e9 des personnes plac\u00e9es sous main de justice","author":"Minist\u00e8re des affaires socIales et de la sant\u00e9 M de la J","year":"2017","unstructured":"Minist\u00e8re des affaires socIales et de la sant\u00e9 M de la J. Strat\u00e9gie Sant\u00e9 des personnes plac\u00e9es sous main de justice. 2017."},{"key":"6357_CR37","volume-title":"AFEF guidelines management of hepatitis C virus infection","author":"P Hillon","year":"2015","unstructured":"Hillon P, Fontaine H, Hanslik B, H\u00e9zode C, de L\u00e9dinghen V, Pageaux G-P, et al. AFEF guidelines management of hepatitis C virus infection. 2015."},{"key":"6357_CR38","volume-title":"Il percorso clinico-assistenziale per le persone detenute","author":"Servizio Salute Mentale DP e S nelle C","year":"2015","unstructured":"Servizio Salute Mentale DP e S nelle C. Il percorso clinico-assistenziale per le persone detenute. 2015."},{"key":"6357_CR39","unstructured":"Casa di Reclusione di Padova. Linee guida sull\u2019HIV\/AIDS e le epatiti in carcere. Milan; 1999. Available from \n                    http:\/\/www.ristretti.it\/areestudio\/salute\/norme\/guidaaids.htm\n                    \n                  ."},{"key":"6357_CR40","unstructured":"Bessa CFB, Lazo GN, Sauret GV, Sauret GV. Improving prison conditions by strengthening the monitoring of HIV, HCV, TB and harm reduction mapping report - Catalonia (Spain) report by OSPDH -Observatory of the Penal System and Human Rights (University of Barcelona). Barcelona. 2015."},{"key":"6357_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4321\/S1575-06202007000100005","volume":"9","author":"P Saiz de la Hoya-zam\u00e1cola","year":"2007","unstructured":"Saiz de la Hoya-zam\u00e1cola P, Marco-Mouri\u00f1o A, Clemente-Ricote G, Portilla-Sogorb J, Boix-Mart\u00ednez V, N\u00fa\u00f1ez-Mart\u00ednez O, et al. Recomendaciones de expertos sobre el diagn\u00f3stico y tratamiento de la hepatitis C cr\u00f3nica en el medio penitenciario. Rev Esp Sanid Penit. 2007;9:27\u201338.","journal-title":"Rev Esp Sanid Penit"},{"key":"6357_CR42","doi-asserted-by":"publisher","unstructured":"Tavoschi L, Vroling H, Madeddu G, Babudieri S, Monarca R, Noordegraaf-schouten MV, et al. Active case finding for communicable diseases in prison Settings: increasing testing coverage and uptake among the prison population in the European Union \/ European Economic Area. Epidemiol Rev. 2018;40. \n                    https:\/\/doi.org\/10.1093\/epirev\/mxy001\n                    \n                  .","DOI":"10.1093\/epirev\/mxy001"},{"key":"6357_CR43","volume-title":"BBV bulletin: Special Edition. Quarterly update report of the introduction of opt-out BBV testing in prisons from PHE, NHS England and HMPPS","author":"Public Health England","year":"2017","unstructured":"Public Health England. BBV bulletin: Special Edition. Quarterly update report of the introduction of opt-out BBV testing in prisons from PHE, NHS England and HMPPS. 2017. Available from: \n                    https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/666850\/BBV_bulletin_Dec_2017.pdf\n                    \n                  ."},{"key":"6357_CR44","doi-asserted-by":"crossref","unstructured":"Morey S, Hamood A, Valappip M, Jones D, Thompson C, Dhuny J, et al. A universal offer of blood borne virus testing substantially increases diagnosis and treatment of HCV in prisons. J Hepatol. 2018;68(1):s307-S308.","DOI":"10.1016\/S0168-8278(18)30835-3"},{"key":"6357_CR45","first-page":"2018","volume-title":"Poster presented at EASL. Improving detection and management of HCV infection in prisons. EASL 2018 - Eur Assoc Study Liver","author":"N Ekeke","year":"2018","unstructured":"Ekeke N, Francis-Graham S, King T, Demma S, Macdonals D, Rosenberg W. Poster presented at EASL. Improving detection and management of HCV infection in prisons. EASL 2018 - Eur Assoc Study Liver; 2018. p. 2018."},{"key":"6357_CR46","unstructured":"Remy A, Guillaume B, Arnaud H, Hakim B, St\u00e9phane M. COMPASS project. Inside and outside link for inmates and PWID with hepatitis B or C in France, first results. Perpignan. 2016. Available from: \n                    https:\/\/www.eiseverywhere.com\/file_uploads\/7cfc55fea5c77cee07bfd9172010b3dd_Andr-JeanRemy-61.pdf\n                    \n                  ."},{"key":"6357_CR47","volume-title":"Prisons et comorbidit\u00e9s - Prise en charge de l\u2019h\u00e9patite C en d\u00e9tention","author":"M Bouteille-Gaillet","year":"2016","unstructured":"Bouteille-Gaillet M. Prisons et comorbidit\u00e9s - Prise en charge de l\u2019h\u00e9patite C en d\u00e9tention. 2016. Available from: \n                    http:\/\/vih.org\/20160607\/prise-en-charge-lhepatite-c-en-detention\/138211\n                    \n                  . [cited 9 May 2018]."},{"key":"6357_CR48","unstructured":"Llerena S, Mateo M, Cobo C, Blasco A, Cabezas J, L\u00e1zaro P, Crespo J. Efficiency of a Telemedicine Program in the Management of Hepatitis C in Inmates. J Hepatol. 2018; 68(S1): 53A. Available from: \n                    https:\/\/aasldpubs.onlinelibrary.wiley.com\/doi\/full\/10.1002\/hep.30256\n                    \n                  . [cited 31 December 2018]."},{"key":"6357_CR49","first-page":"70","volume":"19","author":"J Crespo","year":"2017","unstructured":"Crespo J, Llerena S, Cobo C, Cabezas J. \u00bf Es posible la eliminaci\u00f3n del virus de la hepatitis C en el entorno penitenciario? Rev Esp Sanid Penit. 2017;19:70\u20133.","journal-title":"Rev Esp Sanid Penit"},{"key":"6357_CR50","volume-title":"Descriptors estadistics serveis penitenciaris","author":"Generalitat de Catalunya","year":"2017","unstructured":"Generalitat de Catalunya. Descriptors estadistics serveis penitenciaris. 2017. Available from: \n                    http:\/\/www.gencat.cat\/justicia\/estadistiques_serveis_penitenciaris\/12_pob.html\n                    \n                  . [cited 7 Mar 2018]."},{"key":"6357_CR51","volume-title":"La eliminaci\u00f3n de la hepatitis C en prisi\u00f3n es posible. Predicci\u00f3n de la eliminaci\u00f3n en las prisiones de Catalu\u00f1a (Espa\u00f1a)","author":"A Marco","year":"2017","unstructured":"Marco A, Valls I, Guerrero RA, Turu E. La eliminaci\u00f3n de la hepatitis C en prisi\u00f3n es posible. Predicci\u00f3n de la eliminaci\u00f3n en las prisiones de Catalu\u00f1a (Espa\u00f1a); 2017."},{"key":"6357_CR52","unstructured":"Informe General 2016. Ministerio del Interior Secretar\u00eda General de Instituciones Penitenciarias. 2016. Available from \n                    http:\/\/www.interior.gob.es\/documents\/642317\/1202140\/Informe_General_IIPP_2016_12615039X.pdf\/3d3b743f-4527-453a-a185-2b3976f724bf\n                    \n                  . [cited 31 Dec 2018]."},{"key":"6357_CR53","series-title":"Data presented at GEHEP-SEIMC","volume-title":"El especialista hospitalario. Estrategias para mejorar la coordinacion con otras unidades: Farmacia, prisiones, y centros de tratamientos de adicciones","author":"F Tellez","year":"2017","unstructured":"Tellez F. El especialista hospitalario. Estrategias para mejorar la coordinacion con otras unidades: Farmacia, prisiones, y centros de tratamientos de adicciones. Data presented at GEHEP-SEIMC. 2017. Available from: \n                    http:\/\/www.gehep2017.org\/images\/site\/ponencias\/03_Sabado_30\/Sabado_10.30_11.30h\/Conf_Especial_P_3_F_Tellez.pdf\n                    \n                  ."},{"key":"6357_CR54","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s10096-011-1166-5","volume":"30","author":"PS Hoya De La","year":"2011","unstructured":"De La Hoya PS, Marco A, Garc\u00eda-Guerrero J, Rivera A. Hepatitis c and b prevalence in Spanish prisons. Eur J Clin Microbiol Infect Dis. 2011;30:857\u201362.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"6357_CR55","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.eimc.2008.07.003","volume":"27","author":"J Murcia","year":"2009","unstructured":"Murcia J, Portilla J, Bedia M, Palazon JM, Sanchez-Paya J, de la Hoya Saiz P, et al. Chronic hepatitis C virus infection and associated liver disease among the inmates of a Spanish prison. Enferm Infecc Microbiol Clin. 2009;27:206\u201312.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"6357_CR56","unstructured":"Public Health England. Health and Justice Report 2014. London. p. 2015. Available from: \n                    https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/562775\/Health_and_justice_report_2014.PDF\n                    \n                  . [cited 31 December 2018]."},{"key":"6357_CR57","first-page":"e554","volume":"38","author":"J Darke","year":"2016","unstructured":"Darke J, Cresswell T, McPherson S, Hamoodi A. Hepatitis C in a prison in the North East of England: What is the economic impact of the universal offer of testing and emergent medications? J Public Heal (United Kingdom). 2016;38:e554\u201362.","journal-title":"J Public Heal (United Kingdom)"},{"key":"6357_CR58","series-title":"Final report","volume-title":"Hepatitis C prevalence and incidence among Scottish prisoners and staff views of its management","author":"A Taylor","year":"2012","unstructured":"Taylor A, Munro A, Allen E, Dunleavy K, Cameron S, Miller L. Hepatitis C prevalence and incidence among Scottish prisoners and staff views of its management. Final report. 2012."},{"key":"6357_CR59","first-page":"P3.442","volume-title":"Experience of Screening For Hepatitis C in an Oxfordshire Prison FREE","author":"S Duncan","year":"2013","unstructured":"Duncan S, Sherrard J. Experience of Screening For Hepatitis C in an Oxfordshire Prison FREE; 2013. p. P3.442."},{"key":"6357_CR60","doi-asserted-by":"publisher","unstructured":"Kirwan P, Evans B, Brant L. Hepatitis C and B testing in English prisons is low but increasing. J Public Health (Bangkok). 2011. \n                    https:\/\/doi.org\/10.1093\/pubmed\/fdr011\n                    \n                  .","DOI":"10.1093\/pubmed\/fdr011"},{"key":"6357_CR61","series-title":"Presented at WHO Regional Office for Europe international meeting on prisons and health in joint collaboration with Public Health England (PHE) and European Monitoring Centre for Drugs and Drug A","volume-title":"HCV elimination in prison is feasible: a French experience","author":"F Meroueh","year":"2017","unstructured":"Meroueh F. HCV elimination in prison is feasible: a French experience. Presented at WHO Regional Office for Europe international meeting on prisons and health in joint collaboration with Public Health England (PHE) and European Monitoring Centre for Drugs and Drug A. 2017. Available from: \n                    https:\/\/justica.gov.pt\/Portals\/0\/Programa%20do%20Encontro%20Internacional%20sobre%20a%20Sa\u00fade%20nas%20Pris\u00f5es%20-%2011%20dez%2017.pdf?ver=2017-12-13-164252-827\n                    \n                  . [cited 10 May 2018]."},{"key":"6357_CR62","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/eurpub\/ckv183","volume":"26","author":"C Jacomet","year":"2016","unstructured":"Jacomet C, Guyot-l\u00e9nat A, Bonny C, Henquell C, Rude M, Dydymski S, et al. Addressing the challenges of chronic viral infections and addiction in prisons\u00a0: the PRODEPIST study. Eur J Pub Health. 2016;26:122\u20138.","journal-title":"Eur J Pub Health"},{"key":"6357_CR63","doi-asserted-by":"publisher","unstructured":"Semaille C, Le SY, Chiron E, Chemlal K, Valantin MA, Serre P, et al. Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy separator commenting unavailable. Eurosurveillance. 2013;18. \n                    https:\/\/doi.org\/10.2807\/1560-7917.ES2013.18.28.20524\n                    \n                  .","DOI":"10.2807\/1560-7917.ES2013.18.28.20524"},{"key":"6357_CR64","volume-title":"Traiter le VHC en prison: une initiative salutaire. Assoc pour la Commun sur les Prison l\u2019incarc\u00e9ration en Eur","author":"F Meroueh","year":"2008","unstructured":"Meroueh F. Traiter le VHC en prison: une initiative salutaire. Assoc pour la Commun sur les Prison l\u2019incarc\u00e9ration en Eur. 2008. Available from: \n                    http:\/\/prison.eu.org\/spip.php?article10630\n                    \n                  . [cited 9 May 2018]."},{"key":"6357_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2014-005694","volume":"4","author":"P Roux","year":"2014","unstructured":"Roux P, Sagaon-Teyssier L, Lions C, Fugon L, Verger P, Carrieri MP. HCV seropositivity in inmates and in the general population: an averaging approach to establish priority prevention interventions. BMJ Open. 2014;4:1\u201310.","journal-title":"BMJ Open"},{"key":"6357_CR66","doi-asserted-by":"publisher","unstructured":"Verneuil L, Vidal JS, Ze Bekolo R, Vabret A, Petitjean J, Leclercq R, et al. Prevalence and risk factors of the whole spectrum of sexually transmitted diseases in male incoming prisoners in France. Eur J Clin Microbiol Infect Dis. 2009. \n                    https:\/\/doi.org\/10.1007\/s10096-008-0642-z\n                    \n                  .","DOI":"10.1007\/s10096-008-0642-z"},{"key":"6357_CR67","unstructured":"Agenzia Regionale di Sanit\u00e0 dellaToscana. La salute dei detenuti in Italia: i risultati di uno studio multicentrico. Toscana; 2015. Available from: \n                    http:\/\/www.sanita24.ilsole24ore.com\/pdf2010\/Sanita2\/_Oggetti_Correlati\/Documenti\/Regioni-e-Aziende\/Carcere.pdf\n                    \n                  . [cited 31 December 2018]."},{"key":"6357_CR68","first-page":"2142","volume":"16","author":"E Sagnelli","year":"2012","unstructured":"Sagnelli E, Starnini G, Sagnelli C, Monarca R, Zumbo G, Pontali E, et al. Blood born viral infections, sexually transmitted diseases and latent tuberculosis in Italian prisons: a preliminary report of a large multicenter study. Eur Rev Med Pharmacol Sci. 2012;16:2142.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"6357_CR69","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1186\/1471-2458-13-981","volume":"13","author":"M Brandolini","year":"2013","unstructured":"Brandolini M, Novati S, De Silvestri A, Tinelli C, Patruno SFA, Ranieri R, et al. Prevalence and epidemiological correlates and treatment outcome of HCV infection in an Italian prison setting. BMC Public Health. 2013;13:981 [cited 9 Feb 2016].","journal-title":"BMC Public Health"},{"key":"6357_CR70","volume-title":"Occurrence and correlates of HIV and hepatitis B\/C virus infections among prisoners of Southern Lazio, Italy","author":"G Torre La","year":"2012","unstructured":"La Torre G, Vezzo D, Arcese R. Occurrence and correlates of HIV and hepatitis B\/C virus infections among prisoners of Southern Lazio, Italy; 2012."},{"key":"6357_CR71","first-page":"297","volume":"35","author":"F Voller","year":"2011","unstructured":"Voller F, Silvestri C, Orsini C, Aversa L, Da MF, Cipriani F. The health conditions of prison inmates in Tuscany. Epidemiol Prev. 2011;35:297\u2013306.","journal-title":"Epidemiol Prev"},{"key":"6357_CR72","unstructured":"Eckert J, Weilandt C. Infektionskrankheiten unter Gefangenen in Deutschland: Kenntnisse, Einstellungen und Risikoverhalten, Teilergebnisse des Projekts: \u201cInfectious Diseases in German Prisons - Epidemiological and Sociological Surveys among Inmates and Staff\u201d. Bonn; 2008. Available from: \n                    http:\/\/www.ahnrw.de\/newsletter\/upload\/01_NL_ahnrw\/2008\/2008_10_01_NL20\/Endbericht_Gefangene_060808_kompl.pdf\n                    \n                  . [cited 31 December 2018]."},{"key":"6357_CR73","unstructured":"Radun D, Weilandt C, Eckert J, Sch\u00fcttler C, Weid F, K\u00fccherer C. Cross- sectional study on seroprevalence regarding hep b, hep c and hiv, risk behaviour, knowledge and attitudes about bloodbone infections among adult prisoners in Germany \u2013 Preliminary Results. Eur Sci Conf Appl Infect Dis Epidemiol - ESCAIDE. 2007; Available from: \n                    http:\/\/www.daignet.de\/site-content\/die-daig\/fachorgan\/pdfs\/eur-j-med-res12-suppl-II-143.pdf\n                    \n                  . [cited 31 December 2018]."},{"key":"6357_CR74","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/17449200802692144","volume":"5","author":"B Schulte","year":"2009","unstructured":"Schulte B, Stover H, Thane K, Schreiter C, Gansefort D, Reimer J. Substitution treatment and HCV\/HIV-infection in a sample of 31 German prisons for sentenced inmates. Int J Prison Health. 2009;5:39\u201344.","journal-title":"Int J Prison Health"},{"key":"6357_CR75","doi-asserted-by":"publisher","unstructured":"Meyer MF, Wedemeyer H, Monazahian M, Dressman J, Manns MP, Lehmann M. Prevalence of hepatitis C in a German prison for young men in relation to country of birth. Epidemiol Infect. 2007. \n                    https:\/\/doi.org\/10.1017\/S0950268806006820\n                    \n                  .","DOI":"10.1017\/S0950268806006820"},{"key":"6357_CR76","volume-title":"Descriptors estadistics de Serveis Penitenciaris I de Rehabilitaci\u00f3","author":"Departament de Just\u00edcia","year":"2018","unstructured":"Departament de Just\u00edcia. Descriptors estadistics de Serveis Penitenciaris I de Rehabilitaci\u00f3. 2018. Available from: \n                    http:\/\/www.gencat.cat\/justicia\/estadistiques_serveis_penitenciaris\/1_pob.html\n                    \n                  . [cited 23 Apr 2018]."},{"key":"6357_CR77","unstructured":"Anuario Estad\u00edstico del Ministerio del Interior 2017. Ministerio del Interior. 2017. Available from \n                    http:\/\/www.interior.gob.es\/documents\/642317\/1204854\/Anuario_estadistico_2017_con_accesibilidad_EN_LINEA.pdf\/09bb0218-7320-404c-9dd5-58f4edec914f\n                    \n                  . [cited 31 Dec 2018]."},{"key":"6357_CR78","unstructured":"Offender Management Statistics. England & Wales prison population 2017. London; 2017. Available from: \n                    https:\/\/www.gov.uk\/government\/statistics\/offender-management-statistics-quarterly-april-to-june-2017\n                    \n                  . [cited 31 December 2018]."},{"key":"6357_CR79","unstructured":"Minist\u00e8re de la Justice. Les chiffres-cl\u00e9s de la Justice 2017. Paris; 2017. Available from: \n                    http:\/\/www.justice.gouv.fr\/art_pix\/stat_Chiffres%20Cl%E9s%202017.pdf\n                    \n                  . [cited 31 December 2018]."},{"key":"6357_CR80","series-title":"Statistiche","volume-title":"Detenuti presenti - aggiornamento al 28 febbraio 2017 28","author":"Ministero Della Giustizia","year":"2017","unstructured":"Ministero Della Giustizia. Detenuti presenti - aggiornamento al 28 febbraio 2017 28. Statistiche. 2017. Available from: \n                    https:\/\/www.giustizia.it\/giustizia\/it\/mg_1_14_1.page?facetNode_1=1_5_36&contentId=SST1315635&previsiousPage=mg_1_14\n                    \n                  . [cited 11 Jan 2018]."},{"key":"6357_CR81","unstructured":"Statistisches Bundesamt. Rechtspflege: Bestand der Gefangenen und Verwahrten in den deutschen Justizvollzugsanstalten nach ihrer Unterbringung auf Haftpl\u00e4tzen des geschlossenen und offenen Vollzugs jeweils zu den Stich- tagen 31, M\u00e4rz, 31. August und 30. November eines Jahres. Wiesbaden; 2017. Available from: \n                    https:\/\/www.destatis.de\/DE\/ZahlenFakten\/GesellschaftStaat\/Bevoelkerung\/Ehescheidungen\/Tabellen\/EhescheidungenKinder.html\n                    \n                  . [cited 31 December 2018]."},{"key":"6357_CR82","unstructured":"Secreteria General de Instituciones Penitenciarias. Informe General 2016. Madrid; 2016."},{"key":"6357_CR83","unstructured":"Istituto Nazionale di Statistica. I Detenuti Nelle Carceri Italiane. Rome; 2015. Available from: \n                    http:\/\/www.istat.it\n                    \n                  . [cited 31 December 2018]."},{"key":"6357_CR84","unstructured":"Bundesministerium f\u00fcr Gesundheit. Strategie zur Eind\u00e4mmung von HIV, Hepatitis B und C und anderen sexuell \u00fcbertragbaren Infektionen, BIS 2023 - Bedarfsorientiert, Integriert, Sektor\u00fcbergreifend. Berlin; 2016. Available from: \n                    https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Praevention\/Broschueren\/Strategie_BIS_2030_HIV_HEP_STI.pdf\n                    \n                  . [cited 31 December 2018]."},{"key":"6357_CR85","volume-title":"Physical health of people in prison","author":"National institute for Health and Care Excellence","year":"2016","unstructured":"National institute for Health and Care Excellence. Physical health of people in prison. 2016. Available from: \n                    https:\/\/www.nice.org.uk\/guidance\/ng57\n                    \n                  ."},{"key":"6357_CR86","unstructured":"AFEF guidelines. Recommandations AFEF sur la prise en charge des h\u00e9patites virales C. Available from \n                    https:\/\/afef.asso.fr\/wp-content\/uploads\/2018\/06\/Recoavril2016.pdf\n                    \n                  ."},{"key":"6357_CR87","unstructured":"Sarzotti C, Unito DS. Interventi di riduzione del danno efficaci secondo le linee guida internazionali 2013. Torino; 2013."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-018-6357-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-018-6357-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-018-6357-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:04:35Z","timestamp":1578441875000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-018-6357-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,8]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6357"],"URL":"https:\/\/doi.org\/10.1186\/s12889-018-6357-x","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,8]]},"assertion":[{"value":"10 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"30"}}